Michael Shapiro to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Michael Shapiro has written about Randomized Controlled Trials as Topic.
Connection Strength
0.421
-
Mahmood T, Minnier J, Ito MK, Li QH, Koren A, Kam IW, Fazio S, Shapiro MD. Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies. Eur J Prev Cardiol. 2021 Jul 23; 28(8):816-822.
Score: 0.149
-
Kheiri B, Barbarawi M, Bachuwa G, Shapiro MD. Aspirin for Primary Prevention of Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 06; 12(6):e005846.
Score: 0.141
-
Shapiro MD, Tavori H, Fazio S. PCSK9: From Basic Science Discoveries to Clinical Trials. Circ Res. 2018 05 11; 122(10):1420-1438.
Score: 0.131